SoftBank’s Vision Fund tumbles to $18 billion loss in ‘valley of coronavirus’
Japan’s SoftBank Group Corp reported a stunning $18 billion loss at its giant Vision Fund, pushing Masayoshi Son’s conglomerate to a record loss and highlighting...
Huawei calls U.S. move to curb chips supply ‘arbitrary’, expects business impact
Huawei Technologies in its first official response to the Trump administration’s move to curb its access to global chip supplies called it “arbitrary” and said...
Indonesia reports 496 new coronavirus infections, 43 deaths
Indonesia reported on Monday 496 new coronavirus infections, taking the total in the Southeast Asian country to 18,010, said health ministry official Achmad Yurianto...
‘A beautiful day’ in Italy, as shops and bars finally reopen
Italian shops, hairdressers and restaurants finally threw open their doors on Monday as the country sped up efforts to bounce back from the coronavirus crisis...
Vatican, Italy start return to religious normal as public Masses resume
Pope Francis inaugurated the full reopening of St. Peter’s Basilica on Monday and Catholic churches held public Masses for the first time in two months...
U.S. likely to back call for independent evaluation of WHO’s handling of coronavirus: envoys
Health ministers from around the world are expected to call for an independent evaluation of the World Health Organization’s handling of the COVID-19 pandemic during...
SoftBank Vision Fund records $18 bln operating loss, portfolio slides underwater
Japan’s SoftBank Group Corp reported a stunning $18 billion loss at its giant Vision Fund, pushing Masayoshi Son’s conglomerate to a record loss and highlighting...
Yemen’s Saudi-backed government pleads for coronavirus aid
Yemen’s Saudi-backed government accused its Houthi foes of covering up a big outbreak of coronavirus in areas they hold and the United Nations warned that...
European shares rise on economic awakening; oil and gold jump
European stock markets rose on Monday and oil prices climbed to their highest in more than a month as a loosening of coronavirus shutdowns boosted...
Remdesivir close to EU’s initial authorisation as COVID-19 treatment
The head of the European Union’s medicines agency Guido Rasi said on Monday an initial authorisation for U.S. pharmaceutical company Gilead’s remdesivir as a COVID-19...